Cell biology of pathologic renal calcification: Contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles

Journal of Investigative Medicine

Volumn 54, Issue 7, 2006, Pages 412-424

  Kumar, Vivek ^a   Farell, Gerard ^a   Yu, Shihui ^a   Harrington, Sean ^a   Fitzpatrick, Lorraine ^a   Rzewuska, Ewa ^a   Miller, Virginia M ^a   Lieske, John C ^a  

^a Mayo Clinic   (United States)

Author keywords

Bone sialoprotein; Continuous inner medullary collecting duct cells; Nanobacteria; Nephrolithiasis; Osteopontin

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; BONE SIALOPROTEIN; CALCIUM OXALATE; GLYCEROL 2 PHOSPHATE; NANOPARTICLE; OSTEOPONTIN;

CALCIUM OXALATE STONE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; KIDNEY CALCIFICATION; KIDNEY COLLECTING TUBULE; KIDNEY INTERSTITIUM; NEPHROLITHIASIS; OSTEOBLAST; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; RANDALL PLAQUE; TRANSCYTOSIS;

BACTERIA (MICROORGANISMS); RATTUS;

EID: 33846310734     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2006.06021     Document Type: Conference Paper

References (74)

1. Unwin R, Wrong O, Cohen E, et al. Unraveling of the molecular mechanisms of kidney stones. Lancet 1996;348:1561-5.
2. National Kidney and Urological Diseases Advisory Board 1990 long range plan: window on the 21st century. J Urol 1991;145:S68-93.
3. Randall A. The origin and growth of renal calculi. Ann Surg 1937;105:1009-20.
4. Randall A. Papillary pathology as precursor of primary renal calculus. J Urol 1940;44:580-9.
5. Cifuentes Delatte L, Minon-Cifuentes J, Medina JA. New studies on papillary renal calculi. J Urol 1987;137:1024-9.
6. Stoller ML, Low RK, Shami GS, et al. High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall's plaque formation. J Urol 1996;156:1263-6.
7. Low RK, Stoller ML. Endoscopic mapping of renal papillae for Randall's plaques in patients with urinary stone disease. J Urol 1997;158:2062-4.
8. Evan AP, Lingeman JE, Coe FL, et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003;111:602-5.
9. Robertson WG, Peacock M, Nordin BEC. Calcium oxalate crystalluria and urine saturation in recurrent renal stone formers. Clin Sci 1971;40:365-74.
10. Dent CE, Sutor DJ. Presence or absence of inhibitor of calcium-oxalate crystal growth in urine of normals and of stone-formers. Lancet 1971;1:776-8.
11. Robertson WG, Peacock M, Marshall RW, et al. Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N Engl J Med 1976;294:249-52.
12. Felix R, Monod A, Broge L, et al. Aggregation of calcium oxalate crystals: effect of urine and various inhibitors. Urol Res 1977;5:21-8.
13. Lieske JC, Norris R, Swift H, Toback FG. Adhesion, internalization and metabolism of calcium oxalate monohydrate crystals by renal epithelial cells. Kidney Int 1997;52:1291-301.
14. Lieske JC, Norris R, Toback FG. Adhesion of hydroxyapatite crystals to anionic sites on the surface of renal epithelial cells. Am J Physiol 1997;273:F224-33.
15. Kumar V, Farell G, Lieske JC. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells. J Urol 2003;170:221-5.
16. Chauvet MC, Ryall RL. Intracrystalline proteins and calcium oxalate crystal degradation in MDCK II cells. J Struct Biol 2005;151:12-7.
17. Scurr DS, Robertson WG. Modifiers of calcium oxalate crystallization found in urine. III. Studies on the role of Tamm-Horsfall mucoprotein and of ionic strength. J Urol 1986;136:505-7.
18. Hess B, Nakagawa Y, Coe FL. A new spectrophotometric method for measuring calcium oxalate monohydrate crystal aggregation in the absence of supersaturation: inhibitory effects of urinary glycoproteins. Urol Res 1989;17:149-50.
19. Grover PK, Moritz RL, Simpson RJ, Ryall RL. Inhibition of growth and aggregation of calcium oxalate crystals in vitro-a comparison of four human proteins. Eur J Biochem 1998;253:637-44.
20. Asplin JR, Arsenault D, Parks JH, et al. Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 1998;53:194-9.
21. Enghild JJ, Thorgersen IB, Cheng F, et al. Organization of the inter-alpha-inhibitor heavy chains on the chondroitin sulfate originating from ser10 of bikunin: posttranslational modification of IaI-derived bikunin. Biochemistry 1999;38:11804-13.
22. Stapleton AMF, Ryall RL. Crystal matrix protein: getting blood out of a stone. Miner Electrolyte Metab 1994;20:299-309.
23. Hess B, Nakagawa Y, Parks JH, Coe FL. Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol 1991;260:F569-78.
24. Knörle R, Schnierle P, Koch A, et al. Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopy. Clin Chem 1994;40:1739-43.
25. Schnierle P. A simple diagnostic method for the differentiation of Tamm-Horsfall glycoproteins from healthy probands and those from recurrent calcium oxalate renal stone formers. Experientia 1995;51:1068-72.
26. Jefferson A, Reynolds TM, Elves A, Wierzbicki AS. Patients with recurrent renal stones have a physico-chemically altered urinary Tamm-Horsfall glycoprotein profile. Ann Clin Biochem 1996;33(Pt 6):540-4.
27. Durrbaum D, Rodgers AL, Sturrock ED. A study of crystal amtrix extract and urinary prothrombin fragment 1 from a stone prone and stone free population. Urol Res 2001;29:83-8.
28. Kumar V, Pena de la Vega L, Farell G, Lieske JC. Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers. Kidney Int 2005;68:1784-92.
29. Mo L, Huang HY, Zhu XH, et al. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 2004;66:1159-66.
30. Wesson JA, Johnson RJ, Mazzali M, et al. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 2003;14:139-47.
31. Sumitra K, Pragasam V, Sakthivel R, et al. Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm-Horsfall glycoprotein in hypertensive and hyperoxaluric patients. Nephrol Dial Transplant 2005;20:1407-15.
32. Lieske JC, Leonard R, Swift HS, Toback FG. Adhesion of calcium oxalate monohydrate crystals to anionic sites on the surface of renal epithelial cells. Am J Physiol 1996;270:F192-9.
33. Bigelow MW, Wiessner JH, Kleinman JG, Mandel NS. Surface exposure of phosphatidylserine increases calcium oxalate crystal attachment. Am J Physiol 1997;272:F55-62.
34. Yamate T, Kohri K, Umekawa T, et al. Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell. J Urol 1999;160:1506-12.
35. Sorokina EA, Kleinman JG. Cloning and preliminary characterization of a calcium-binding protein closely related to nucleolin on the apical surface of inner medullary collecting duct cells. J Biol Chem 1999;274:27491-6.
36. Verkoelen CF, Van Der Boom BG, Romijn JC. Identification of hyaluronan as a crystal-binding molecule at the surface of migrating and proliferating MDCK cells. Kidney Int 2000;58:1045-54.
37. Kumar V, Farell G, Deganello S, Lieske JC. Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals. J Am Soc Nephrol 2003;14:289-97.
38. Farell G, Huang E, Kim SY, et al. Modulation of proliferating renal epithelial cell affinity for calcium oxalate monohydrate crystals. J Am Soc Nephrol 2004;15:3052-62.
39. Lieske JC, Spargo B, Toback FG. Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol 1992;148:1517-9.
40. Saxon A, Busch GJ, Merrill JP, et al. Renal transplantation in primary hyperoxaluria. Arch Intern Med 1974;133:464-7.
41. Mandell I, Krauss E, Millan JC. Oxalate-induced acute renal failure in Crohn's disease. Am J Med 1980;69:628-32.
42. Wharton R, D'Agati V, Magun AM, et al. Acute deterioration of renal function associated with enteric hyperoxaluria. Clin Nephrol 1990;34:116-21.
43. Gelbart DR, Brewer LL, Fajardo LF, Weinstein AB. Oxalosis and chronic renal failure after intestinal bypass. Arch Intern Med 1977;137:239-43.
44. Hering F, Briellmann T, Luoend G, et al. Stone formation in the human kidney. Urol Res 1987;15:67-73.
45. Gonlusen G, Akgun H, Ertan A, et al. Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing: clinical patterns and renal biopsy findings. Arch Pathol Lab Med 2006;130:101-6.
46. Carr G, Simmons NL, Sayer JA. Disruption of clc-5 leads to a redistribution of annexin A2 and promotes calcium crystal agglomeration in collecting duct epithelial cells. Cell Mol Life Sci 2006;63:367-77.
47. Verhulst A, Asselman M, De Naeyer S, et al. Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis. Kidney Int 2005;68:1643-7.
48. Chen NX, Moe SM. Vascular calcification in chronic kidney disease. Semin Nephrol 2004;24:61-8.
49. Bostrom K, Watson KE, Horn S, et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993;91:1800-9.
50. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 1994;94:1597-604.
51. Shanahan CM, Cary NR, Salisbury JR, et al. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999;100:63-8.
52. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994;93:2393-402.
53. Kleinman JG, Sorokina EA. Cloning and preliminary characterization of a calcium-binding protein closely related to nucleolin on the apical surface of inner medullary collecting duct cells. J Biol Chem 1999;274:27941-6.
54. Wada T, McKee MD, Steitz S, Giachelli CM. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 1999;84:166-78.
55. Kajander EO, Kuronen I, Akerman K, et al. Nanobacteria from blood, the smallest culturable autonomously replicating agent on earth. Proc SPIE 1997;3111:420-8.
56. Ciftcioglu N, Pelttari A, Kajander EO. Extraordinary growth phases of nanobacteria isolated from mammalian blood. Proc SPIE 1997 3111, 429-35.
57. Hjelle JT, Miller-Hjelle MA, Poxton IR, et al. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 2000;57:2360-74.
58. Akerman KK, Kuikka JT, Ciftcioglu N, et al. Radiolabeling and in vivo distribution of nanobacteria in rabbit. Proc SPIE 1997;3111:436-42.
59. Ciftcioglu N, Bjorklund M, Kuorikoski K, et al. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 1999;56:1893-8.
60. Ciftcioglu N, Miller-Hjelle MA, Hjelle JT, Kajander EO. Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 2002;46:2077-86.
61. Khullar M, Sharma SK, Singh SK, et al. Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population. Urol Res 2004;32:190-5.
62. Cisar JO, Xu D-Q, Thompson J, et al. An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci U S A 2000;97:11511-5.
63. Kim K. Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc 1976;35:156-62.
64. Miller VM, Rodgers G, Charlesworth JA, et al. Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 2004;287:H1115-24.
65. Kajander EO, Ciftcioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 1998;95:8274-9.
66. Mattern KL, Evans CA, Lara JC. Selective antibacterial action of 2-mercaptoethanol on propionobacteria in skin cultures. Appl Environ Microbiol 1979;37:177-9.
67. Inui K, Oreffo ROC, Triffit JT. Effects of beta mercaptoethanol on the proliferation and differentiation of human osteoprogenitor cells. Cell Biol Int 1997;21:419-25.
68. Johnsen AR, Bendixen K, Karlson U. Detection of microbial growth on polycyclic aromatic hydrocarbons in microtiter plates by using the respiration indicator WST-1. Appl Environ Microbiol 2002;68:2683-9.
69. Jenkins C, Fuerst JA. Phylogenetic analysis of evolutionary relationships of the planctomycete division of the domain bacteria based on amino acid sequences of elongation factor Tu. J Mol Evol 2001;52:405-18.
70. Chaudhuri TK, Farr GW, Fenton WA, et al. GroEL/GroES-mediated folding of a protein too large to be encapsulated. Cell 2001;107:235-46.
71. Baldauf SL, Palmer JD, Doolittle WF. The root of the universal tree and the origin of eukaryotes based on elongation factor phylogeny. Proc Natl Acad Sci U S A 1996;93:7749-54.
72. Weissman JS. The ins and outs of GroEL-mediated protein folding. Mol Cell 2001;8:730-2.
73. Mohanty BK, Kushner SR. Polynucleotide phosphorylase functions both as a 3′ right arrow 5′ exonuclease and a poly(A) polymerase in Escherichia coli. Proc Natl Acad Sci USA 2000;97:11966-71.
74. Baumann C, Judex M, Huber H, Wirth R. Estimation of genome sizes of hyperthermophiles. Extremophiles 1998;2:101-8.